Allergan plc buy melinda
Start price
21.03.17
/
50%
€213.82
Target price
06.12.18
€248.05
Performance (%)
3.13%
End price
06.12.18
€216.67
Summary
This prediction ended on 06.12.18 with a price of €216.67. With a performance of 3.13%, the BUY prediction by melinda for Allergan plc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Allergan plc | - | - | - | - |
iShares Core DAX® | 0.936% | 1.535% | 21.949% | 19.324% |
iShares Nasdaq 100 | 3.064% | 1.968% | 29.275% | 38.772% |
iShares Nikkei 225® | 1.898% | -0.295% | 14.740% | 1.986% |
iShares S&P 500 | 1.653% | 2.318% | 27.064% | 40.403% |
Comments by melinda for this prediction
In the thread Allergan plc diskutieren
Allergan FDA
Allergan erhielt die Genehmigung von der US Food and Drug Administration (FDA) Juvederm XC VOLLURETM, zur Korrektur von mittelschweren bis schweren Gesichtsfalten und Falten, wie Nasolabialfalten, bei älteren Erwachsenen über 21 auf den Markt.
(Laufzeit überschritten)